Skip to main content

Table 2 Mean VAS weights and mean and median TTO weights, per health state

From: Disability Adjusted Life Years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens

Health state and length of illness

 

VAS

TTO

 
 

n

mean

median

mean

sd

%0a

Gastroenteritis

      

Gastroenteritis, mild, 1 day

51

0.036

0

0.002

0.01

88

Gastroenteritis, mild, 5 days

53

0.102

0

0.010

0.04

60

Gastroenteritis, moderate, 10 days

107

0.130

0.005

0.015

0.04

26

Gastroenteritis, severe, 7 days

53

0.231

0.008

0.025

0.05

25

Gastroenteritis, severe, 14 days

51

0.295

0.011

0.041

0.07

17

Gastroenteritis, chronic, 6 months

53

0.368

0.058

0.099

0.11

8

Guillain-Barré syndrome b

      

Guillain-Barré syndrome, F1, whole year

51

0.185

0.008

0.044

0.09

40

Guillain-Barré syndrome, F2, whole year

107

0.420

0.077

0.137

0.18

7

Guillain-Barré syndrome, F3, whole year

53

0.545

0.153

0.215

0.23

2

Guillain-Barré syndrome, F4, whole year

51

0.700

0.252

0.367

0.32

2

Guillain-Barré syndrome, F5, whole year

53

0.722

0.403

0.460

0.31

0

Reactive arthritis

      

Reactive arthritis, mild, 1 week

51

0.107

0

0.004

0.01

68

Reactive arthritis, mild, 6 weeks

53

0.197

0.011

0.023

0.03

25

Reactive arthritis, moderate, 6 months

53

0.447

0.058

0.115

0.13

8

Reactive arthritis, severe, 6 months

51

0.503

0.153

0.186

0.16

4

Hemolytic Uremic Syndrome (HUS)

      

HUS, moderate, 1 month

53

0.279

0.022

0.056

0.08

13

HUS, severe, 1 month

51

0.481

0.038

0.110

0.19

0

Renal failure, whole year

51

0.628

0.252

0.328

0.25

0

Inflammatory bowel disease

      

Crohn disease, 6 months

51

0.347

0.067

0.105

0.12

4

Colitis ulcerosa, 6 months

53

0.492

0.115

0.154

0.15

7

  1. a percentage of participants that were not willing to trade-off any time in order to be restored from the health state.
  2. b for a detailed description of the five health states of patients with Guillain-Barré syndrome, see Havelaar et al. [8]